Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie Stock Update: Humira Growth Set To Increase
Bidness, ETC
Wed, 09/16/15 - 10:22 am
AbbVie
Humira
AbbVie edges closer to Imbruvica deal payoff with another FDA filing
Fierce Pharma
Tue, 09/15/15 - 03:16 pm
AbbVie
Imbruvica
FDA
JNJ
CLL
chronic lymphocytic leukemia
Why Shares of Halozyme Therapeutics Inc. Plunged 24% in August
Motley Fool
Sun, 09/13/15 - 11:55 am
Halozyme
PEGPH20
AbbVie
AbbVie Posts Another Win for Humira
Yahoo/24-7 Wall St
Thu, 09/10/15 - 06:05 pm
Humira
AbbVie
Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug
Fierce Biotech
Tue, 09/1/15 - 06:38 pm
AbbVie
Bristol-Myers Squibb
FDA
elotuzumab
Multiple Myeloma
AbbVie scores one against FTC in pay-for-delay AndroGel suit
Fierce Pharma
Thu, 08/27/15 - 11:34 am
AbbVie
FTC
Androgel
pay-for-delay
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
White House urged to stop states' 'rationing' of hep C drugs
Fierce Pharma
Wed, 08/26/15 - 11:56 am
hepatitis C
Medicaid
Harvoni
Gilead Sciences
AbbVie
Viekira Pak
Who should Allergan buy next?
Fierce Pharma
Tue, 08/25/15 - 02:10 pm
Allergan
M&A
AbbVie
Shire
Amgen
Biogen
Gilead Sciences, Inc. Harvoni Vs. AbbVie Inc Humira: Which Would Be Best-Selling Drug Of 2015?
Bidness, ETC
Tue, 08/25/15 - 08:56 am
Gilead Sciences
Harvoni
AbbVie
Humira
AbbVie could end up sidestepping lost sales tied to an expiring patent on Humira in 2017
Motley Fool
Sun, 08/23/15 - 11:40 am
AbbVie
Humira
patents
Imbruvica
autoimmune disease
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle
Seeking Alpha
Sat, 08/22/15 - 08:53 am
spinoffs
AbbVie
Abbott Labs
Baxalta
Baxter
Why Four Months Is Worth $350m To AbbVie And Filgotinib
Seeking Alpha
Fri, 08/21/15 - 05:19 pm
AbbVie
filgotinib
FDA
review vouchers
priority review
Did AbbVie Just Make an Incredibly Brilliant Decision?
Motley Fool
Fri, 08/21/15 - 09:31 am
AbbVie
priority review
review vouchers
United Therapeutics
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
AbbVie
priority review
Roche
CLL
chronic lymphocytic leukemia
United Therapeutics
AbbVie buys special review voucher for $350 mln
Yahoo/Reuters
Wed, 08/19/15 - 12:25 pm
AbbVie
priority review
review vouchers
United Therapeutics
4 Top Pharma Stocks That Should Outperform Out To 2016
24/7 Wall St
Tue, 08/18/15 - 09:44 am
AbbVie
Bristol-Myers Squibb
Eli Lilly
Merck
AbbVie Challenges Fairness Of Upcoming Testosterone Trials
Forbes
Mon, 08/17/15 - 07:18 pm
AbbVie
testosterone
Androgel
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
AbbVie
Amgen
biosimilars
JNJ
Sandoz
Novartis
Humira
Neupogen
Remicade
Nuelasta
Enbrel
epoetin-alfa
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Galapagos
AbbVie
JAK inhibitors
rheumatoid arthritis
filgotinib
Pages
« first
‹ previous
…
52
53
54
55
56
57
58
59
60
…
next ›
last »